Literature DB >> 3128262

The time course of hydrolysis of a beta-lactam antibiotic by intact gram-negative bacteria possessing a periplasmic beta-lactamase.

W W Nichols1.   

Abstract

An equation is derived from first principles for describing the change in concentration with time of a beta-lactam antibiotic in the presence of intact Gram-negative bacteria possessing a beta-lactamase located in the periplasmic space. The equation predicts a first-order decline in beta-lactam concentration of the form [S] = [Si]e lambda t, where [S] is the exogenous concentration of beta-lactam, [Si] is the value of [S] at time zero, t is the time from mixing of cells and antibiotic and lambda (less than 0) is the decay constant. The value of lambda is exactly described by the theory in terms of experimentally measurable quantities. Quantitative data concerning cephaloridine hydrolysis by intact cells of Haemophilus influenzae agreed well with the theory, as did data concerning the uptake of 2-nitrophenyl galactoside by intact cells of Escherichia coli. Cephalosporin C hydrolysis by intact cells of Pseudomonas aeruginosa did not progress as predicted by the theory. The theory is applicable to any substrate which is acted on by an enzyme that is located solely in the periplasmic space and that obeys the Michaelis-Menten equation of enzyme kinetics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3128262      PMCID: PMC1148025          DOI: 10.1042/bj2440509

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

Review 1.  An explicit model for bacterial resistance: application to beta-lactam antibiotics.

Authors:  S G Waley
Journal:  Microbiol Sci       Date:  1987-05

2.  When is the outer membrane of Escherichia coli rate-limiting for uptake of galactosides?

Authors:  I C West; M G Page
Journal:  J Theor Biol       Date:  1984-09-07       Impact factor: 2.691

3.  Alternative-substrate inhibition and the kinetic mechanism of the beta-galactoside/proton symport of Escherichia coli.

Authors:  M G Page; Y H Jou
Journal:  Biochem J       Date:  1982-06-15       Impact factor: 3.857

4.  An easy method for the determination of initial rates.

Authors:  S G Waley
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

5.  Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane.

Authors:  R E Hancock; P G Wong
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

6.  The permeability barrier of Haemophilus influenzae type b against beta-lactam antibiotics.

Authors:  J W Coulton; P Mason; D Dorrance
Journal:  J Antimicrob Chemother       Date:  1983-11       Impact factor: 5.790

7.  Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics.

Authors:  W Zimmermann; A Rosselet
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

8.  Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes.

Authors:  F Yoshimura; H Nikaido
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

9.  The kinetics of the beta-galactoside-proton symport of Escherichia coli.

Authors:  M G Page; I C West
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

10.  Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant.

Authors:  B L Angus; A M Carey; D A Caron; A M Kropinski; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

View more
  2 in total

1.  Contribution of the cell-surface-associated enzyme in the Zimmermann-Rosselet assay of outer membrane permeability of beta-lactam antibiotics.

Authors:  W Liu; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

2.  Modeling the Kinetics of the Permeation of Antibacterial Agents into Growing Bacteria and Its Interplay with Efflux.

Authors:  Wright W Nichols
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.